The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 7, 2009, Pages 2325-2330

  Kim, Hyun Ju ^a,b   Zhang, Kaihua ^a   Zhang, Lihong ^a   Ross, F Patrick ^a   Teitelbaum, Steven L ^a   Faccio, Roberta ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b Kyungpook National University School of Medicine   (South Korea)

Author keywords

c Src; Osteoclast; SFK

Indexed keywords

ENZYME LYN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHOPROTEIN; PROTEIN GAB2; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE SHP 1; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; BONE RESORPTION; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MICE, INBRED C57BL; MUTATION; NF-KAPPA B; OSTEOCLASTS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; RANK LIGAND; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

MUS;

EID: 60549103884     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0806963106     Document Type: Article

References (47)

1. Teitelbaum SL (2000) Bone resorption by osteoclasts. Science 289:1504-1508.
2. Teitelbaum SL, Ross FP (2003) Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638-649.
3. Lowell CA, Soriano P (1996) Knockouts of Src-family kinases: stiff bones, wimpy T cells, and bad memories. Genes Dev 10:1845-1857.
4. Faccio R, Novack DV, Zallone A, Ross FP, Teitelbaum SL (2003) Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by β3 integrin. J Cell Biol 162:499-509.
5. Sanjay A, et al. (2001) Cbl associates with Pyk2 and Src to regulate Src kinase activity, αvβ3 integrin-mediated signaling, cell adhesion, and osteoclast motility. J Cell Biol 152:181-196.
6. Soriano P, Montgomery C, Geske R, Bradley A (1991) Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693-702.
7. Zou W, et al. (2007) Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J Cell Biol 176:877-888.
8. Faccio R, et al. (2007) M-CSF regulates the cytoskeleton via recruitment of a multimeric signaling complex to c-Fms Tyr-559/697/721. J Biol Chem 282:18991-18999.
9. Wong BR, et al. (1999) TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cell 4:1041-1049.
10. Wada T, et al. (2005) The molecular scaffold Gab2 is a crucial component of RANK signaling and osteoclastogenesis. Nat Med 11:394-399.
11. Tanaka S, Nakamura K, Takahasi N, Suda T (2005) Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol Rev 208:30-49.
12. David JP, Sabapathy K, Hoffmann O, Idarraga MH, Wagner EF (2002) JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J Cell Sci 115:4317-4325.
13. Hibbs ML, Dunn AR (1997) Lyn, a src-like tyrosine kinase. Int J Biochem Cell Biol 29:397-400.
14. Horne WC, et al. (1992) Osteoclasts express high levels of pp60 c-src in association with intracellular membranes. J Cell Biol 119:1003-1013.
15. Harder KW, et al. (2001) Gain- and loss-of-function Lyn mutant mice define a critical inhibitory role for Lyn in the myeloid lineage. Immunity 15:603-615.
16. Kurosaki T (1999) Genetic analysis of B cell antigen receptor signaling. Ann Rev Immunol 17:555-592.
17. Vidalain PO, et al. (2000) CD40 signaling in human dendritic cells is initiated within membrane rafts. EMBO J 19:3304-3313.
18. Nishizumi H, Horikawa K, Mlinaric-Rascan I, Yamamoto T (1998) A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals. J Exp Med 187:1343-1348.
19. Chan VW, Meng F, Soriano P, DeFranco AL, Lowell CA (1997) Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7:69-81.
20. Hernandez-Hansen V, Mackay GA, Lowell CA, Wilson BS, Oliver JM (2004) The Src kinase Lyn is a negative regulator of mast cell proliferation. J Leukoc Biol 75:143-151.
21. Odom S, et al. (2004) Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J Exp Med 199:1491-1502.
22. Baran CP, et al. (2003) The inositol 5′-phosphatase SHIP-1 and the Src kinase Lyn negatively regulate macrophage colony-stimulating factor-induced Akt activity. J Biol Chem 278:38628-38636.
23. Pereira S, Lowell C (2003) The Lyn tyrosine kinase negatively regulates neutrophil integrin signaling. J Immunol 171:1319-1327.
24. Malbec O, et al. (1998) Fc{epsilon} receptor I-associated Lyn-dependent phosphorylation of Fc{gamma} receptor IIB during negative regulation of mast cell activation. J Immunol 160:1647-1658.
25. Umeda S, et al. (1999) Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density. Am J Pathol 155:223-233.
26. Aoki K, et al. (1999) The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: increased resorption and osteopenia in mev/mev mutant mice. Bone 25:261-267.
27. Takeshita S, et al. (2002) SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts. Nat Med 8:943-949.
28. Parravicini V, et al. (2002) Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat Immunol 3:741-748.
29. Shultz LD, et al. (1993) Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73:1445-1454.
30. Mundy GR (2007) Osteoporosis and inflammation. Nutr Rev 65:S147-S151.
31. Boyce BF, Yoneda T, Lowe C, Soriano P, Mundy GR (1992) Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. J Clin Invest 90:1622-1627.
32. Boyce BF, et al. (2006) Src inhibitors in metastatic bone disease. Clin Cancer Res 12:6291s-6295s.
33. Insogna KL, et al. (1997) Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts. J Clin Invest 100:2476-2485.
34. Malbec O, Attal J-P, Fridman WH, Daeron M (2002) Negative regulation of mast cell proliferation by FcγRIIB. Mol Immunol 38:1295-1299.
35. Maeda A, et al. (1999) Paired immunoglobulin-like receptor B (PIR-B) inhibits BCR-induced activation of Syk and Btk by SHP-1. Oncogene 18:2291-2297.
36. Lowell CA (2004) Src-family kinases: rheostats of immune cell signaling. Mol Immunol 41:631-643.
37. Koga T, et al. (2004) Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428:758-763.
38. Pereira S, Zhang H, Takai T, Lowell CA (2004) The inhibitory receptor PIR-B negatively regulates neutrophil and macrophage integrin signaling. J Immunol 173:5757-5765.
39. Adams S, et al. (1998) Signal-regulatory protein is selectively expressed by myeloid and neuronal cells. J Immunol 161:1853-1859.
40. Aoki K, et al. (1999) The tyrosine phosphatase SHP-1 is a negative regulator of osteoclastogenesis and osteoclast resorbing activity: Increased resorption and osteopenia in mev/mev mutant mice. Bone 25:261-267.
41. Zhang Z, Jimi E, Bothwell ALM (2003) Receptor activator of NF-{kappa}B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis. J Immunol 171:3620-3626.
42. Bai S, et al. (2005) FHL2 inhibits the activated osteoclast in a TRAF6-dependent manner. J Clin Invest 115:2742-2751.
43. Novack DV, et al. (2003) The IκB function of NF-κB2 p100 controls stimulated osteoclastogenesis. J Exp Med 198:771-781.
44. Vaira S, et al. (2008) RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. J Clin Invest 118:2088-2097.
45. Vaira S, et al. (2008) RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation. Proc Natl Acad Sci USA 105:3897-3902.
46. Kim HJ, et al. (2006) Glucocorticoids suppress bone formation via the osteoclast. J Clin Invest 116:2152-2160.
47. Mao D, Epple H, Uthgenannt B, Novack DV, Faccio R (2006) PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. J Clin Invest 116:2869-2879.